• Pathogenic Fungi

Pathogenic Fungi in Microbiology

Fungi are eukaryotic microorganisms that can cause a variety of diseases in humans, animals, and plants. Pathogenic fungi are classified based on their morphology, mode of reproduction, and the type of infections they cause.

---

Classification of Pathogenic Fungi

1. Based on Morphology

1. Yeasts:
   • Unicellular, reproduce by budding or fission.
   • Example: Candida albicans.
2. Molds:
   • Multicellular, filamentous fungi with hyphae.
   • Example: Aspergillus fumigatus.
3. Dimorphic Fungi:
   • Exist as molds at lower temperatures (environment) and as yeasts at body temperature (host).
   • Example: Histoplasma capsulatum.

---

2. Based on Infection Type

1. Superficial Mycoses:
   • Affect outermost layers of skin, hair, and nails.
   • Example: Malassezia furfur (causes pityriasis versicolor).
2. Cutaneous Mycoses:
   • Infect keratinized tissues such as skin, hair, and nails.
   • Example: Dermatophytes (Trichophyton, Microsporum, Epidermophyton).
3. Subcutaneous Mycoses:
   • Involve deeper layers of skin, subcutaneous tissue, and sometimes bone.
   • Example: Sporothrix schenckii (causes sporotrichosis).
4. Systemic (Deep) Mycoses:
   • Affect internal organs; often caused by dimorphic fungi.
   • Example: Histoplasma capsulatum, Blastomyces dermatitidis.
5. Opportunistic Mycoses:
   • Occur in immunocompromised individuals.
   • Example: Candida albicans, Aspergillus fumigatus, Cryptococcus neoformans.

---

Examples of Pathogenic Fungi and Associated Diseases

1. Superficial Mycoses

• Organism: Malassezia furfur.
• Disease: Pityriasis versicolor.
• Symptoms:
  • Hypopigmented or hyperpigmented scaly patches on the skin.
• Treatment:
  • Topical azoles (ketoconazole).

---

2. Cutaneous Mycoses

• Organism: Dermatophytes (Trichophyton, Microsporum, Epidermophyton).
• Disease: Tinea infections (e.g., ringworm, athlete’s foot).
• Symptoms:
  • Red, scaly, itchy lesions.
• Treatment:
  • Topical antifungals (clotrimazole, terbinafine).

---

3. Subcutaneous Mycoses

• Organism: Sporothrix schenckii.
• Disease: Sporotrichosis (“rose gardener’s disease”).
• Symptoms:
  • Nodular lesions along lymphatic channels.
• Treatment:
  • Itraconazole or potassium iodide.

---

4. Systemic Mycoses

1. Histoplasmosis:
   • Organism: Histoplasma capsulatum.
   • Transmission: Inhalation of spores from bird or bat droppings.
   • Symptoms:
     • Fever, cough, fatigue.
     • Severe cases: Disseminated disease in immunocompromised hosts.
   • Treatment:
     • Itraconazole (mild cases), Amphotericin B (severe cases).
2. Blastomycosis:
   • Organism: Blastomyces dermatitidis.
   • Symptoms:
     • Pulmonary and cutaneous lesions.
   • Treatment:
     • Itraconazole or Amphotericin B.
3. Coccidioidomycosis:
   • Organism: Coccidioides immitis, Coccidioides posadasii.
   • Symptoms:
     • Flu-like symptoms, joint pain, skin nodules.
   • Treatment:
     • Fluconazole, Amphotericin B.

---

5. Opportunistic Mycoses

1. Candidiasis:
   • Organism: Candida albicans.
   • Diseases:
     • Oral thrush, vaginal candidiasis, systemic candidiasis.
   • Symptoms:
     • White plaques in oral cavity, itching in vaginal infections.
   • Treatment:
     • Topical azoles (local), fluconazole (systemic).
2. Aspergillosis:
   • Organism: Aspergillus fumigatus.
   • Diseases:
     • Allergic bronchopulmonary aspergillosis (ABPA), invasive aspergillosis.
   • Symptoms:
     • Cough, hemoptysis, fever (invasive form).
   • Treatment:
     • Voriconazole or Amphotericin B.
3. Cryptococcosis:
   • Organism: Cryptococcus neoformans.
   • Transmission: Inhalation of spores, often from pigeon droppings.
   • Symptoms:
     • Meningitis in immunocompromised patients (e.g., HIV/AIDS).
   • Treatment:
     • Amphotericin B with flucytosine.
4. Mucormycosis (Zygomycosis):
   • Organism: Rhizopus, Mucor species.
   • Risk Factors:
     • Uncontrolled diabetes, immunosuppression.
   • Symptoms:
     • Rapidly spreading necrosis, particularly in the sinuses and brain.
   • Treatment:
     • Amphotericin B and surgical debridement.

---

Pathogenesis of Fungal Infections

1. Adherence:
   • Fungi adhere to host tissues using adhesins.
2. Invasion:
   • Secrete enzymes (e.g., proteases, lipases) to penetrate tissues.
3. Immune Evasion:
   • Capsule formation (Cryptococcus neoformans).
   • Dimorphism (Histoplasma capsulatum).
4. Tissue Damage:
   • Toxins and immune responses cause tissue destruction.

---

Laboratory Diagnosis of Fungal Infections

1. Microscopy:
   • Direct examination of clinical specimens using KOH mount, calcofluor white staining.
2. Culture:
   • Sabouraud Dextrose Agar (SDA) for fungal growth.
3. Histopathology:
   • Special stains: PAS (Periodic Acid-Schiff), Gomori Methenamine Silver (GMS).
4. Serological Tests:
   • Detection of fungal antigens or antibodies (e.g., galactomannan for Aspergillus).
5. Molecular Techniques:
   • PCR for fungal DNA.

---

Treatment of Fungal Infections

Antifungal Drugs

1. Polyenes:
   • Example: Amphotericin B.
   • Mechanism: Binds to ergosterol, disrupting fungal membranes.
2. Azoles:
   • Examples: Fluconazole, itraconazole.
   • Mechanism: Inhibit ergosterol synthesis.
3. Echinocandins:
   • Example: Caspofungin.
   • Mechanism: Inhibit fungal cell wall synthesis.
4. Flucytosine:
   • Mechanism: Inhibits fungal DNA and RNA synthesis.
5. Topical Agents:
   • Examples: Clotrimazole, terbinafine.

---

Prevention of Fungal Infections

1. Hygiene:
   • Maintain personal hygiene to prevent superficial infections.
2. Avoidance:
   • Avoid exposure to contaminated soil or droppings (e.g., Histoplasma, Cryptococcus).
3. Immunization:
   • No vaccines currently available for most fungal infections.
4. Prophylactic Antifungals:
   • Used in high-risk patients (e.g., fluconazole in transplant recipients).

• Dermatophytes

Dermatophytes

Dermatophytes are a group of fungi that infect keratinized tissues such as skin, hair, and nails. These fungi cause dermatophytosis, also known as tinea or ringworm, which are superficial infections affecting humans and animals.

---

Characteristics of Dermatophytes

1. Morphology:
   • Filamentous fungi with septate hyphae.
   • Produce macroconidia and microconidia during reproduction.
   • Visible under KOH mount or in culture.
2. Keratinophilic:
   • Use keratin as a nutrient source, enabling them to colonize keratinized tissues.
3. Classification:
   • Belong to three main genera:
     • Trichophyton.
     • Microsporum.
     • Epidermophyton.
4. Transmission:
   • Direct contact with infected individuals, animals, or contaminated objects (fomites).

---

Classification of Dermatophytes

1. Based on Natural Habitat

1. Anthropophilic:
   • Prefer humans as hosts.
   • Cause mild to chronic infections.
   • Examples:
     • Trichophyton rubrum.
     • Epidermophyton floccosum.
2. Zoophilic:
   • Prefer animals as hosts but can infect humans.
   • Cause inflammatory infections.
   • Examples:
     • Microsporum canis.
     • Trichophyton verrucosum.
3. Geophilic:
   • Found in soil; infect humans and animals occasionally.
   • Cause highly inflammatory infections.
   • Examples:
     • Microsporum gypseum.

---

Common Dermatophytoses (Tinea Infections)

1. Tinea Capitis (Scalp Ringworm)

• Causative Agents:
  • Microsporum audouinii, Trichophyton tonsurans.
• Symptoms:
  • Scalp scaling, hair loss, kerion (inflammatory mass).
• Population Affected:
  • Mainly children.

2. Tinea Corporis (Body Ringworm)

• Causative Agents:
  • Trichophyton rubrum, Microsporum canis.
• Symptoms:
  • Circular, red, scaly lesions on body.

3. Tinea Pedis (Athlete’s Foot)

• Causative Agents:
  • Trichophyton rubrum, Epidermophyton floccosum.
• Symptoms:
  • Itchy, scaly, fissured skin between toes.

4. Tinea Cruris (Jock Itch)

• Causative Agents:
  • Trichophyton rubrum, Epidermophyton floccosum.
• Symptoms:
  • Itchy, red patches in groin and inner thighs.

5. Tinea Unguium (Onychomycosis)

• Causative Agents:
  • Trichophyton rubrum, Trichophyton mentagrophytes.
• Symptoms:
  • Thickened, discolored, brittle nails.

6. Tinea Barbae (Beard Ringworm)

• Causative Agents:
  • Trichophyton verrucosum, Trichophyton mentagrophytes.
• Symptoms:
  • Inflammatory pustules in beard area.

7. Tinea Faciei (Face Ringworm)

• Causative Agents:
  • Trichophyton rubrum, Trichophyton mentagrophytes.
• Symptoms:
  • Scaly, red patches on the face.

---

Pathogenesis

1. Adherence to Keratinized Tissues:
   • Dermatophytes adhere to keratinized tissues via specialized adhesins.
2. Keratin Degradation:
   • Secrete keratinases and other proteolytic enzymes to digest keratin, allowing colonization.
3. Immune Evasion:
   • Produce metabolites that inhibit host immune responses.
4. Inflammatory Response:
   • Host immune response causes redness, itching, and scaling.

---

Laboratory Diagnosis

1. Direct Microscopy:
   • KOH Mount:
     • 10–20% potassium hydroxide dissolves keratin, leaving fungal hyphae visible.
     • Branched, septate hyphae or arthroconidia can be seen.
2. Culture:
   • Media:
     • Sabouraud Dextrose Agar (SDA) with antibiotics to inhibit bacterial growth.
   • Colony Morphology:
     • Colonies can be white, fluffy, or pigmented depending on the species.
3. Wood’s Lamp:
   • Ultraviolet light reveals fluorescent infected hairs in some Microsporum species.
4. Histopathology:
   • Periodic Acid-Schiff (PAS) staining shows fungal elements in tissues.
5. Molecular Techniques:
   • PCR for species-specific identification.

---

Treatment of Dermatophytoses

1. Topical Antifungals:

• For mild or localized infections.
• Examples:
  • Clotrimazole, terbinafine, ketoconazole.

2. Systemic Antifungals:

• For extensive, severe, or hair/nail infections.
• Examples:
  • Terbinafine, itraconazole, fluconazole, griseofulvin.

3. Adjunct Therapy:

• Keep affected areas dry and clean.
• Use antifungal powders for prevention.

---

Prevention

1. Personal Hygiene:
   • Regular washing and drying of skin and hair.
   • Avoid sharing personal items (e.g., towels, combs).
2. Environmental Control:
   • Disinfect contaminated objects and surfaces.
3. Protective Measures:
   • Wear footwear in public showers or swimming pools.
4. Treatment of Carriers:
   • Treat infected pets and asymptomatic carriers.

---

Public Health Significance

1. Widespread Prevalence:
   • Dermatophytes are a common cause of skin infections globally.
   • Particularly prevalent in warm and humid climates.
2. Impact on Quality of Life:
   • Chronic infections can cause discomfort and social stigma.
3. Zoonotic Potential:
   • Some dermatophytes, like Microsporum canis, can spread from animals to humans.

• Systemic mycotic infection

Systemic Mycotic Infections

Systemic mycotic infections are caused by fungi that can invade internal organs and tissues, often affecting immunocompromised individuals. These infections are primarily caused by dimorphic fungi and opportunistic fungi.

---

Key Characteristics of Systemic Mycotic Infections

1. Dimorphic Fungi:
   • Exist as molds in the environment (at 25°C) and as yeast forms in host tissues (at 37°C).
   • Can infect immunocompetent individuals.
   • Examples: Histoplasma capsulatum, Blastomyces dermatitidis, Coccidioides immitis.
2. Opportunistic Fungi:
   • Infect primarily immunocompromised individuals (e.g., HIV/AIDS, organ transplant patients).
   • Examples: Candida albicans, Aspergillus fumigatus, Cryptococcus neoformans, Mucor species.
3. Route of Infection:
   • Typically acquired via inhalation of fungal spores, leading to primary pulmonary infections.
   • Dissemination occurs to other organs in severe cases.

---

Common Systemic Mycoses

1. Histoplasmosis

• Causative Agent: Histoplasma capsulatum.
• Transmission:
  • Inhalation of spores from bird or bat droppings.
• Pathogenesis:
  • Spores are inhaled into the lungs, where they convert to yeast forms.
  • Yeasts survive within macrophages and disseminate.
• Clinical Forms:
  • Acute pulmonary histoplasmosis: Fever, cough, chest pain.
  • Chronic pulmonary histoplasmosis: Mimics tuberculosis.
  • Disseminated histoplasmosis: Affects multiple organs, severe in immunocompromised patients.
• Diagnosis:
  • Histopathology: Yeasts inside macrophages.
  • Serology: Detection of antigen in urine or blood.
  • Culture: Growth on Sabouraud Dextrose Agar.
• Treatment:
  • Itraconazole (mild cases), Amphotericin B (severe cases).

---

2. Blastomycosis

• Causative Agent: Blastomyces dermatitidis.
• Transmission:
  • Inhalation of spores from soil and decaying organic matter.
• Pathogenesis:
  • Spores transform into thick-walled yeasts in the lungs and can disseminate.
• Clinical Forms:
  • Pulmonary blastomycosis: Cough, fever, chest pain.
  • Cutaneous blastomycosis: Verrucous skin lesions.
  • Disseminated blastomycosis: Affects bones, skin, CNS.
• Diagnosis:
  • Microscopy: Broad-based budding yeast.
  • Culture: Growth on SDA.
  • Antigen detection in urine or serum.
• Treatment:
  • Itraconazole (mild cases), Amphotericin B (severe cases).

---

3. Coccidioidomycosis (Valley Fever)

• Causative Agent: Coccidioides immitis, Coccidioides posadasii.
• Transmission:
  • Inhalation of arthroconidia from soil.
• Pathogenesis:
  • Arthroconidia transform into spherules in tissues, releasing endospores.
• Clinical Forms:
  • Primary pulmonary coccidioidomycosis: Fever, cough, arthralgia, erythema nodosum.
  • Disseminated coccidioidomycosis: Affects skin, bones, CNS.
• Diagnosis:
  • Microscopy: Spherules with endospores.
  • Serology: Complement fixation test.
  • Culture: Highly infectious; performed in specialized labs.
• Treatment:
  • Fluconazole or itraconazole (mild cases), Amphotericin B (severe cases).

---

4. Cryptococcosis

• Causative Agent: Cryptococcus neoformans, Cryptococcus gattii.
• Transmission:
  • Inhalation of spores from pigeon droppings.
• Pathogenesis:
  • Capsulated yeast evades phagocytosis and disseminates, especially to the CNS.
• Clinical Forms:
  • Pulmonary cryptococcosis: Cough, chest pain.
  • Cryptococcal meningitis: Headache, fever, altered mental status.
• Diagnosis:
  • India ink preparation: Encapsulated yeasts.
  • Antigen detection in CSF or serum.
  • Culture on SDA.
• Treatment:
  • Amphotericin B with flucytosine (acute cases), Fluconazole (maintenance).

---

5. Aspergillosis

• Causative Agent: Aspergillus fumigatus, Aspergillus flavus.
• Transmission:
  • Inhalation of conidia from the environment.
• Clinical Forms:
  • Allergic bronchopulmonary aspergillosis (ABPA): Asthma-like symptoms.
  • Aspergilloma: Fungus ball in pre-existing lung cavities.
  • Invasive aspergillosis: Severe infection in immunocompromised patients, affecting lungs, brain, and other organs.
• Diagnosis:
  • Microscopy: Acute-angle branching septate hyphae.
  • Culture: Growth on SDA.
  • Galactomannan antigen detection.
• Treatment:
  • Voriconazole (preferred), Amphotericin B.

---

6. Mucormycosis (Zygomycosis)

• Causative Agents: Rhizopus, Mucor species.
• Transmission:
  • Inhalation of spores or direct inoculation.
• Clinical Forms:
  • Rhinocerebral mucormycosis: Affects sinuses, brain (common in diabetics).
  • Pulmonary mucormycosis: Severe respiratory infection.
  • Cutaneous mucormycosis: Necrotic lesions.
• Diagnosis:
  • Microscopy: Non-septate hyphae with 90° branching.
  • Culture: Growth on SDA.
• Treatment:
  • Amphotericin B and surgical debridement.

---

Laboratory Diagnosis of Systemic Mycoses

1. Microscopy:
   • Direct examination using KOH mount or special stains like PAS and GMS.
2. Culture:
   • Sabouraud Dextrose Agar for fungal growth.
3. Serology:
   • Detection of fungal antigens or antibodies (e.g., galactomannan for Aspergillus).
4. Molecular Techniques:
   • PCR for rapid identification of fungal DNA.
5. Histopathology:
   • Examination of biopsy specimens.

---

Treatment of Systemic Mycoses

1. First-Line Antifungal Drugs:
   • Amphotericin B: Broad-spectrum, used for severe infections.
   • Azoles: Fluconazole, itraconazole, voriconazole for less severe infections.
   • Echinocandins: Caspofungin for invasive aspergillosis or candidiasis.
2. Supportive Care:
   • Management of underlying immunosuppression.
   • Surgical intervention for abscesses or fungal masses.

---

Prevention of Systemic Mycoses

1. Avoid Exposure:
   • Minimize contact with contaminated soil or bird droppings in endemic areas.
2. Prophylactic Antifungals:
   • For high-risk immunocompromised individuals.
3. Public Health Measures:
   • Early diagnosis and treatment to reduce morbidity and mortality.

---

Public Health Significance

• Emerging Threat:
  • Increasing incidence in immunocompromised populations (e.g., HIV/AIDS, organ transplant recipients).
• Zoonotic Potential:
  • Some fungi, like Histoplasma and Cryptococcus, are linked to animal reservoirs.

• Laboratory diagnosis of mycotic infection

Laboratory Diagnosis of Mycotic Infections

Laboratory diagnosis of mycotic (fungal) infections is essential for identifying the causative organism and determining the appropriate treatment. The diagnosis involves a combination of microscopic, cultural, serological, and molecular methods.

---

Steps in Laboratory Diagnosis

1. Sample Collection and Transport

1. Specimen Types:
   • Superficial Infections:
     • Skin scrapings, nail clippings, hair.
   • Subcutaneous Infections:
     • Pus, tissue biopsy.
   • Systemic Infections:
     • Blood, cerebrospinal fluid (CSF), sputum, urine, bronchoalveolar lavage (BAL), or tissue biopsy.
2. Transport:
   • Use sterile, leak-proof containers.
   • Avoid contamination with commensal flora.
   • Transport to the laboratory promptly to maintain viability.

---

2. Direct Microscopy

1. Potassium Hydroxide (KOH) Mount:
   • 10–20% KOH dissolves keratin, making fungal elements visible.
   • Detects septate or non-septate hyphae, budding yeasts, or conidia.
   • Example: Diagnosis of dermatophytes.
2. Lactophenol Cotton Blue (LPCB) Staining:
   • Stains fungal elements and highlights their morphology.
   • Useful for observing molds in culture.
3. Special Stains:
   • Calcofluor White:
     • Fluorescent dye binds to fungal cell walls.
   • Periodic Acid-Schiff (PAS):
     • Highlights fungal elements in tissue sections.
   • Gomori Methenamine Silver (GMS):
     • Stains fungal hyphae black; useful for detecting fungi in tissues.
   • India Ink Preparation:
     • Detects the capsule of Cryptococcus neoformans in CSF.
4. Microscopic Observations:
   • Yeasts: Budding cells (Candida).
   • Hyphae:
     • Septate (e.g., Aspergillus).
     • Non-septate (e.g., Mucor).

---

3. Culture

1. Media:
   • Sabouraud Dextrose Agar (SDA):
     • General medium for fungi; may include antibiotics to inhibit bacterial growth.
   • Chromogenic Agar:
     • Differentiates Candida species based on colony color.
   • Brain Heart Infusion (BHI) Agar:
     • Supports growth of dimorphic fungi and systemic pathogens.
   • Cornmeal Agar:
     • Used to identify Candida species.
2. Incubation:
   • Temperature:
     • 25°C for molds.
     • 37°C for yeasts and dimorphic fungi.
   • Duration:
     • 1–4 weeks depending on fungal species.
3. Colony Morphology:
   • Molds: Cottony, velvety, or powdery colonies (e.g., Aspergillus).
   • Yeasts: Creamy, smooth colonies (e.g., Candida).

---

4. Identification of Fungi

1. Microscopic Morphology:
   • Observe conidia, spores, and hyphae under LPCB stain.
   • Example: Septate hyphae and conidia in Aspergillus.
2. Biochemical Tests:
   • Germ Tube Test:
     • Detects Candida albicans by producing germ tubes in serum.
   • Sugar Assimilation/Fermentation:
     • Differentiates Candida and Cryptococcus species.
3. Slide Culture Technique:
   • Maintains fungal morphology for microscopic identification.

---

5. Serological Tests

1. Antigen Detection:
   • Galactomannan:
     • Detects Aspergillus antigen in serum or BAL.
   • Beta-D-Glucan:
     • Indicates invasive fungal infections.
   • Cryptococcal Antigen:
     • Detects Cryptococcus in serum or CSF.
2. Antibody Detection:
   • Limited utility due to cross-reactivity and delayed antibody production.
3. Specific Tests:
   • Histoplasma or Blastomyces antigen in urine or serum.

---

6. Molecular Methods

1. Polymerase Chain Reaction (PCR):
   • Amplifies fungal DNA for rapid and specific identification.
   • Example: Detection of Candida, Aspergillus, Cryptococcus.
2. DNA Sequencing:
   • Identifies fungi at the species level.
3. Matrix-Assisted Laser Desorption/Ionization-Time of Flight (MALDI-TOF):
   • Analyzes fungal proteins for identification.

---

7. Imaging (For Systemic Mycoses)

• Chest X-ray or CT Scan:
  • Detects fungal lesions in the lungs (e.g., Aspergillus).
• MRI or CT:
  • Identifies fungal involvement in the brain or sinuses.

---

Common Mycotic Infections and Diagnostic Methods

Disease	Causative Agent	Specimen	Diagnostic Method
Candidiasis	Candida albicans	Blood, urine, swab	Culture, germ tube test
Cryptococcosis	Cryptococcus neoformans	CSF, blood	India ink, antigen test
Aspergillosis	Aspergillus fumigatus	BAL, tissue	Galactomannan, culture
Histoplasmosis	Histoplasma capsulatum	BAL, urine, blood	Antigen test, culture
Blastomycosis	Blastomyces dermatitidis	Sputum, tissue	Microscopy, culture
Mucormycosis	Rhizopus, Mucor species	Tissue biopsy	Microscopy, culture
Dermatophytosis	Trichophyton species	Skin, nails, hair	KOH mount, culture

---

Strengths and Limitations of Diagnostic Methods

1. Microscopy:
   • Strengths:
     • Rapid and cost-effective.
   • Limitations:
     • Requires expertise; may not differentiate species.
2. Culture:
   • Strengths:
     • Gold standard for identification.
   • Limitations:
     • Time-consuming (weeks for some fungi).
3. Serology:
   • Strengths:
     • Useful for systemic infections.
   • Limitations:
     • Cross-reactivity; low sensitivity in some cases.
4. Molecular Methods:
   • Strengths:
     • Rapid, specific, and sensitive.
   • Limitations:
     • Expensive; not widely available in all laboratories.

---

Advances in Fungal Diagnostics

1. Point-of-Care Tests:
   • Rapid diagnostic kits for Cryptococcus and Candida.
2. Next-Generation Sequencing (NGS):
   • Identifies mixed fungal infections and rare species.
3. Nanotechnology-Based Diagnostics:
   • Highly sensitive detection of fungal biomarkers.